Fischer Laurent

Fischer Laurent is listed in filings as Director at Mirum Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including purchase activity and sale activity. Recent filings connect the profile to Mirum Pharmaceuticals, Inc. (MIRM), Adverum Biotechnologies, Inc. (ADVM), and Atai Beckley Inc. (ATAI). The current snapshot covers public activity from Jun 14, 2024 to Jun 2, 2026. Reported amounts are shown as $1.9M to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.